A Trial of HRS-5965 Capsule in Primary IgA Nephropathy

NCT07014826 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

378

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary IgA Nephropathy

Interventions

DRUG: HRS-5965
DRUG: Placebo

Sponsor

Chengdu Suncadia Medicine Co., Ltd.